Glaucoma: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• VEGF 1
• NRF2 0
• PI3K 0
• STAT3 0
• AMPK 0
• MAPK 0
• AKT 0
• GLP-1 1
• NLRP3 0
• STING 0
• TNF 0
• IL-1 0
• JAK 0
• MMP-9 1
• PPAR 0
• SIRT1 0
• TP53 0
• ACE2 0
• GPX4 0
• IL-6 1
• mTOR 0
• YAP 0
• APOE 0
• BDNF 0
• CD38 0
• CGRP 0
• COX-2 0
• ERK 0
• GIP 0
• HSP90 0
• IL-17 0
• MEK 0
• MYCN 0
• NF1 0
• NMDA 0
• PDGFR 0
• RANKL 0
• RB1 0
• TIM-3 0

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 8
• Organoids 2
• Mendelian Randomization Analysis 24
• CRISPR-Cas Systems 3
• Gene Expression Profiling 15
• Sequence Analysis, RNA 1
• Exome Sequencing 16
• Proteomics 21
• Metabolomics 11
• Mass Spectrometry 4
• Flow Cytometry 7
• Immunohistochemistry 17
• Magnetic Resonance Imaging 21
• Machine Learning 27
• Deep Learning 35
• Cohort Studies 24
• Genome-Wide Association Study 28

• Comparative proteomics of human anterior lens capsules reveals ATP6V1A-associated lysosomal dysregulation in age-related cataract with primary angle-closure glaucoma.

  J Transl Med, Sept 2026

• Canine Tear Proteomics: A New Frontier in Veterinary Ophthalmology.

  Vet Ophthalmol, Sept 2026

• Sex-Dependent Responses in the Retina Proteome to Ocular Hypertension in a Mouse Model of Glaucoma.

  Int J Mol Sci, Aug 2026

• Proteomic Analyses of Early Versus Advanced Primary Open-Angle Glaucoma Uncover Biochemical Signatures Associated With Disease Staging.

  Mol Cell Proteomics, Jul 2026

• Proteomic Profile Analysis of Plasma and Aqueous Humor from Glaucoma and Nonglaucomatous Patients.

  J Ocul Pharmacol Ther, Jul 2026

• Transcending genome-wide association studies to create useful multi-omic views of glaucoma.

  Prog Retin Eye Res, Jul 2026

• Integrative Multi-Omics Analysis Prioritizes Candidate Therapeutic Targets for Primary Open-Angle Glaucoma.

  Int J Mol Sci, May 2026

• Multi-omics panorama of glaucoma: Pathogenesis, biomarkers, and novel therapeutic strategies.

  Surv Ophthalmol, May 2026

• Integrated plasma proteomics and metabolomics reveal immunometabolic pathways and predictive signatures for age-related eye diseases.

  Metabolism, Apr 2026

• Advances in the application of metal-organic frameworks in ophthalmology.

  Biomater Sci, Apr 2026

See which targets of this disease your abstract mentions, and go to the people working on them.